Each dot is one of the 19 Life Sciences Tools stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 6.9% and the median P/E 36.97. Pinned to the edge: 0 outliers on X and 2 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | TMOThermo Fisher Scientific | 7.2% | 36.21 | $252.30B | Life Sciences Tools |
| 2 | DHRDanaher | 4.6% | 40.90 | $163.76B | Life Sciences Tools |
| 3 | BDXBecton Dickinson | 17.4% | 56.90 | $53.54B | Medical Supplies |
| 4 | AAgilent Technologies | 8.6% | 34.31 | $49.41B | Life Sciences Tools |
| 5 | IDXXIdexx Laboratories | 12.8% | 39.47 | $44.98B | Animal Health |
| 6 | ILMNIllumina | 4.9% | 49.15 | $40.55B | Life Sciences Tools |
| 7 | MTDMettler Toledo International | 6.9% | 36.97 | $33.48B | Industrial Machinery |
| 8 | IRIngersoll Rand | 7.8% | 30.48 | $29.23B | Pumps and Valves |
| 9 | STESteris | 8.4% | 27.78 | $22.36B | Medical Devices |
| 10 | RVTYRevvity | 4.1% | 75.17 | $17.86B | Life Sciences Tools |
| 11 | TECHBio-Techne | -0.4% | 62.30 | $11.33B | Life Sciences Tools |
| 12 | QGENQiagen | 3.0% | 26.74 | $10.94B | Life Sciences Tools |
| 13 | RGENRepligen | 16.5% | 243.45OUT | $10.11B | Life Sciences Tools |
| 14 | DCIDonaldson | 5.3% | 21.95 | $9.96B | Industrial Machinery |
| 15 | BIOBio-Rad Laboratories | 1.4% | 44.64 | $9.93B | Life Sciences Tools |
| 16 | BLFSBiolife Solutions | 25.4% | 32.54 | $1.89B | Life Sciences Tools |
| 17 | MLABMesa Laboratories | 3.0% | 152.92OUT | $734.00M | Life Sciences Tools |
| 18 | LABStandard Biotools | -4.8% | 2.75 | $233.24M | Life Sciences Tools |
| 19 | JANLJanel | 16.0% | 10.42 | $56.94M | Logistics |
Among Life Sciences Tools stocks, the largest companies growing revenue faster than the median (6.9%) while trading below the median P/E (36.97) are Thermo Fisher Scientific (TMO), Agilent Technologies (A), Ingersoll Rand (IR), Steris (STE) and Biolife Solutions (BLFS). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Danaher (DHR), Illumina (ILMN), Revvity (RVTY), Bio-Techne (TECH) and Bio-Rad Laboratories (BIO).
The median P/E across the 19 Life Sciences Tools stocks plotted is 36.97, with the middle half between 29.13 and 53.02.
The median is 6.9%, with the middle half between 3.5% and 10.7%.
The rank correlation (Spearman) is -0.05, a no meaningful negative relationship: knowing one tells you little about the other.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 0 companies are outliers on Revenue Growth (1y) (TTM) and 2 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.